The Oncology Institute, Inc. (TOI) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -2.21M | 3.23M | -12.63M | -10.2M | -4.99M | 4.19M | 819K | -15.66M | -15.88M | -3.89M | -8.31M | -8.66M | -15.45M | -14M | -20.4M | -10.38M | -16.98M | -23.34M | -2.68M | -7.13M |
| Operating CF Margin % | -1.5% | 2.28% | -9.25% | -8.52% | -4.78% | 4.17% | 0.82% | -15.89% | -16.78% | -4.54% | -10.13% | -10.79% | -20.28% | -19.6% | -31.39% | -17.04% | -30.78% | -44.61% | -5.12% | -14.3% |
| Operating CF Growth % | 55.59% | -22.77% | -1642.12% | 34.85% | 68.6% | 207.53% | 109.86% | -80.83% | -2.79% | 72.19% | 59.26% | 16.56% | 9% | 40.02% | -661.44% | -45.57% | -3759.7% | -2412.82% | -2.29% | -18.1% |
| Net Income | -2.49M | 28.72M | -16.5M | -13.99M | -19.59M | -13.18M | -16.11M | -12.68M | -16.27M | -18.75M | -17.42M | -16.9M | -30M | -11.01M | -2.17M | -5.45M | 19.29M | -10.16M | -2.98M | 3.21M |
| Depreciation & Amortization | 1.62M | -1.9M | 1.72M | 1.8M | 1.78M | 1.71M | 1.57M | 1.52M | 1.49M | 1.58M | 1.7M | 1.33M | 1.27M | 1.19M | 1.13M | 1.1M | 987K | 920K | 850K | 794K |
| Stock-Based Compensation | 1.69M | -893K | 1.02M | 0 | 1.46M | 1.29M | 2.39M | 0 | 0 | 4.08M | 4.66M | 4.11M | 4.96M | 6.07M | 0 | 6.51M | 8.55M | 24.38M | 59K | 51K |
| Deferred Taxes | 0 | 32K | 0 | -32K | 0 | 0 | 0 | 0 | 0 | -126K | 80K | -4K | -26K | -446K | 52K | -49K | 180K | 2.3M | -3.76M | 0 |
| Other Non-Cash Items | -3.95M | -30.38M | 7.3M | 5.3M | 8.23M | 1.64M | 1.51M | -1.09M | 1.63M | 2.88M | 3.78M | 1M | 13.12M | -4.59M | -11.81M | -12.76M | -37.99M | -28.1M | 73K | -5.89M |
| Working Capital Changes | 928K | 7.65M | -6.17M | -3.29M | 3.13M | 12.73M | 11.46M | -3.41M | -2.73M | 6.45M | -1.11M | 1.8M | -4.78M | -5.22M | -7.6M | 271K | -7.99M | -12.68M | 3.08M | -5.29M |
| Change in Receivables | -130K | 658K | -4.04M | -8.21M | -985K | 6.18M | -493K | 4.76M | -16.22M | 4.01M | -2.05M | -506K | -5.95M | -5.13M | -6.15M | -3.68M | -4.7M | 1.53M | -2.33M | -1.61M |
| Change in Inventory | -7.42M | 2.01M | -3.1M | -3.48M | -2.27M | 67K | 1.22M | 232K | 2.12M | -1.47M | -6K | -1.91M | -993K | 852K | -851K | -401K | -1.33M | -502K | -1.07M | -282K |
| Change in Payables | 4.61M | 7.71M | 439K | 6.43M | 5.06M | 739K | 7.58M | -5.46M | 6.36M | 1.1M | 210K | 1.18M | 2.57M | -1.78M | -2.75M | 1.3M | -2.96M | -3.33M | 5.3M | 477K |
| Cash from Investing | -1.04M | -1.06M | -604K | -1.21M | -202K | -1.75M | 10.4M | 18.18M | 19.39M | 11.63M | 7.71M | 24.9M | 18.4M | -32.57M | -87.78M | -10.26M | -1M | -9.15M | -950K | -607K |
| Capital Expenditures | -1.04M | 143.59K | -604K | -1.21M | -328K | -1.75M | 402K | -1.83M | -610K | -861K | -930K | -937K | -1.84M | -2M | -1.19M | -1.34M | -1M | -871K | -950K | -407K |
| CapEx % of Revenue | 0.71% | 0.1% | 0.44% | 1.01% | 0.31% | 1.75% | 0.4% | 1.85% | 0.64% | 1% | 1.13% | 1.17% | 2.41% | 2.79% | 1.83% | 2.2% | 1.82% | 1.67% | 1.82% | 0.82% |
| Acquisitions | 0 | -126K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -156K | 0 | 0 | 0 | -470K | 813K | -8.92M | 0 | -8.28M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -1.08M | 0 | 0 | 126K | 0 | 0 | 0 | 0 | 0 | 0 | -4.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -200K |
| Cash from Financing | -28K | 3.73M | 10.6M | 1.96M | -4.74M | -164K | -243K | -2.15M | -938K | -1.78M | -756K | -2.6M | -1.71M | -847K | 105.39M | -10.69M | -1.66M | 136.13M | -8K | -4.51M |
| Debt Issued (Net) | -9K | -9K | -8K | -10K | -20.01M | -10K | -11K | -9K | -9K | -10K | -10K | -63K | -18K | -19K | 102.58M | -13K | -13K | -5.13M | -8K | -4.51M |
| Equity Issued (Net) | 241K | 4.09M | 9.95M | 2.2M | 15.36M | 0 | 0 | 2K | 73K | 0 | -125K | 0 | 0 | -416K | 79K | -8.66M | 0 | 0 | 0 | -20M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -125K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -260K | -350K | 656K | -230K | -89K | -154K | -232K | -2.14M | -1M | -1.77M | -621K | -2.54M | -1.69M | -412K | 2.73M | -2.01M | -1.64M | 141.26M | 0 | 20M |
| Net Change in Cash | -3.29M | 5.91M | -2.63M | -9.45M | -9.93M | 2.27M | 10.98M | 369K | 2.57M | 5.95M | -1.36M | 13.64M | 1.24M | -47.41M | -2.78M | -31.33M | -19.64M | 103.64M | -3.64M | -12.24M |
| Free Cash Flow | -3.26M | 2.17M | -13.23M | -11.41M | -5.32M | 2.43M | 1.22M | -17.49M | -16.49M | -4.75M | -9.24M | -9.6M | -17.29M | -15.99M | -21.59M | -11.72M | -17.98M | -24.21M | -3.63M | -7.74M |
| FCF Margin % | -2.21% | 1.53% | -9.69% | -9.52% | -5.09% | 2.42% | 1.22% | -17.74% | -17.42% | -5.54% | -11.26% | -11.96% | -22.69% | -22.39% | -33.23% | -19.24% | -32.6% | -46.28% | -6.94% | -15.52% |
| FCF Growth % | 38.73% | -10.61% | -1183.87% | 34.75% | 67.77% | 151.14% | 113.21% | -82.2% | 4.62% | 70.27% | 57.2% | 18.12% | 3.85% | 33.93% | -494.9% | -51.49% | -11501.94% | -12980.08% | -25.75% | -23.4% |
| FCF per Share | -0.00 | 0.00 | -0.01 | -0.01 | -0.07 | 0.03 | 0.02 | -0.23 | -0.22 | -0.06 | -0.13 | -0.13 | -0.24 | -0.19 | -0.27 | -0.16 | -0.24 | -0.35 | -0.05 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.89x | -0.43x | 0.77x | 0.60x | 0.25x | -0.32x | -0.05x | 1.01x | 0.80x | 0.21x | 0.48x | 0.51x | 0.52x | 1.27x | 7.63x | 1.90x | -0.88x | 2.30x | 0.90x | -2.22x |
| Interest Paid | 0 | 0 | 878K | 0 | 1.29M | 1.16M | 1.11M | 0 | 0 | 1.12M | 1.13M | 1.13M | 1.13M | 40K | 0 | 61K | 74K | 82K | 56K | 137K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 177K | 56K | 102K | 68K | 124K | 0 | 25K | 0 | 1.3M | 176K | 249K |